734
L. M. Newman et al. / Tetrahedron 60 (2004) 729–734
Table 2. Summary of two-phase cyclization reactions for 4-hydroxy-3[2H]-furanone 1 synthesis
Mass of starting material
Solvent
(volume)
Buffer, amounts of NaH2PO4·H2O and NaHCO3
Temp.
(8C)
Time
(h)
Weight
recovered
Ratio of 1:3
(by NMR)
800 mg
1.3 g
1 g
n-BuOAc (3 mL)
EtOAc (3 mL)
n-BuOAc (5 mL)
n-BuOAc (10 mL)
340 mgþ80 mg
510 mgþ120 mg
425 mgþ100 mg
170 mgþ40 mg
95, then rt
Reflux ,80
95, then rt
110
4–16
22
8–15
22
280 mg
630 mg
390 mg
1.3 g
4:1
1:1
3.5:1
3:1
2.6 g
Progress; Teranishi, R., Wick, E. L., Hornstein, I., Eds.;
Kluwer Academic Plenum: New York, 1999; p 305.
5. Re, L.; Maurer, B.; Ohloff, G. Helv. Chim. Acta 1973, 56,
1882–1894.
experiments were repeated at least 3 times. The experiments
were reproducible up to 2–6 g. The material was analyzed by
TLC, 13C NMR, and 1H NMR with 4-hydroxy-2,5-dimethyl-
2,3-dihydrofuran-3-one1 ascomparativestandard.22 Deutero-
chloroform was used as the solvent and D2O exchange was
also performed. The final 4-hydroxy-2,5-dimethyl-2,3-
dihydrofuran-3-one 1 product is very volatile and oxidizes
readily in the presence of air, as evidenced by appearance of
additional spots on subsequent TLC analysis.
6. (a) Hudlicky, T.; Gonzalez, D.; Gibson, D. T. Aldrichim. Acta
1999, 32, 35–62. (b) Boyd, D. R.; Sheldrake, G. N. Nat. Prod.
Rep. 1998, 309–324. (c) Brown, S. M.; Hudlicky, T. Organic
Synthesis: Theory and Applications, Hudlicky, T., Ed.; JAI:
Greenwich, CT, 1993; Vol. 2, p 113. (d) Hudlicky, T.; Reed,
J. W. In Advances in Asymmetric Synthesis; Hassner, A., Ed.;
JAI: Greenwich, CT, 1995; p 271.
4.8.1. 4-Hydroxy-3,5-dimethyl-3(2H)-furanone-1. 1H NMR
(400 MHz, CDCl3): 7.6 (1H), 4.5 (dq, J¼7, 1 Hz, 1H), 2.26 (d,
J¼1 Hz, 3H), 1.44 (d, J¼7 Hz, 3H). 13C NMR (100 MHz,
CDCl3): 198.84, 174.89, 133.95, 80.02, 16.27, 13.37.
7. Powell, K. A.; Ramer, S. W.; DelCardayre, S. B.; Stemmer,
W. P. C.; Tobin, M. B.; Longchamp, P. F.; Huisman, G.
Angew. Chem. 2001, 40, 3948–3959.
8. Huisman, G. W.; Gray, D. Curr. Opin. Biotechnol. 2002, 13,
352–358.
4.8.2. cis-1,2-Dihydroxy-3,6-dimethyl-hexa-3,5-diene-2.
1H NMR (400 MHz, CDCl3): 5.63 (2H), 4.06 (2H), 2.55
(2H), 1.88 (6H). 13C NMR (100 MHz, CDCl3): 135.14,
120.25, 72.05, 19.48. Compound 2 is unstable and
dehydrates readily to 2,5-dimethylphenol.7 This degradation
9. Boyd, D. R.; Sharma, N. D.; Allen, C. C. R. Curr. Opin.
Biotechnol. 2001, 12, 564–573.
10. Gibson, D. T.; Mahadevan, V.; Davey, J. F. J. Bacteriol. 1974,
119, 930–936.
1
11. Sakamoto, T.; Joern, J. M.; Arisawa, A.; Arnold, F. H. Appl.
Environ. Microbiol. 2001, 67, 3882–3887.
product was detected in the spectra of compound 2: H
NMR (400 MHz, CDCl3): 6.97 (d, J¼7.6 Hz, 1H), 6.63 (d,
12. Kumamaru, T.; Suenaga, H.; Mitsuoka, M.; Watanabe, T.;
Furukawa, K. Nat. Biotechnol. 1998, 16, 663–666.
13. Bruehlmann, F.; Chen, W. Biotechnol. Bioengng 1999, 63,
544–551.
J¼7.6 Hz, 1H), 6.59 (1H), 2.25 (3H), 2.19 (3H).
13C NMR (100 MHz, CDCl3): 163.8, 136.8, 130.66, 121.04,
120.68, 115.62, 20.88, 15.3.
14. Zylstra, G. J.; Gibson, D. T. Genet. Engng 1991, 13, 183–203.
15. Misawa, N.; Shindo, K.; Takahashi, H.; Suenaga, H.; Iguchi,
K.; Okazaki, H.; Harayama, S.; Furukawa, K. Tetrahedron
2002, 58, 9605–9612.
4.8.3. 2,5-Diketo-3,4-dihydroxyhexane-3/methoxyketal–
hemiketal-4 mixture: 3. 1H NMR (400 MHz, CDCl3): 4.38
(2H), 2.31 (6H). 13C NMR (100 MHz, CDCl3): 207.87,
78.53, 16.31. 4: 1H NMR (400 MHz, CDCl3): 3.83 (d,
J¼3.5 Hz, 1H), 3.69 (d, J¼3.5 Hz, 1H), 3.36 (3H), 1.4 (m,
6H). 13C NMR (100 MHz, CDCl3): 105.56, 101.8, 70.89,
66.88, 48.88, 27.03, 21.46.
16. Suenaga, H.; Mitsuoka, M.; Ura, Y.; Watanabe, T.; Furukawa,
K. J. Bacteriol. 2001, 183, 5441–5444.
17. Parales, J. V.; Parales, R. E.; Resnick, S. M.; Gibson, D. T.
J. Bacteriol. 1998, 180, 1194–1199.
18. Barriault, D.; Simard, C.; Chatel, H.; Sylvestre, M. Can.
J. Microbiol. 2001, 47, 1025–1032.
19. Beil, S.; Mason, J. R.; Timmis, K. N.; Pieper, D. H.
J. Bacteriol. 1998, 180, 5520–5528.
Acknowledgements
20. Beil, S.; Happe, B.; Timmis, K. N.; Pieper, D. H. Eur.
J. Biochem. 1997, 247, 190–199.
The project was supported by Maxygen, Inc. Partial support
(T. Hudlicky) was also received by the National Science
Foundation (CHE-9910412). The authors thank Dr. Chris
Davis and Dr. Gjalt Huisman for critical review and
assistance in the preparation of the manuscript.
21. Ensley, B. D.; Ratzkin, B. J.; Osslund, T. D.; Simon, M. J.;
Wackett, L. P.; Gibson, D. T. Science 1983, 222, 167–169.
22. Briggs, M. A.; Haines, A. H.; Jones, H. F. J. Chem. Soc.,
Perkin Trans. 1: Org. Bio-Org. Chem. 1985, 4, 795–798.
23. Lageveen, R. G.; Huisman, G. W.; Preusting, H.; Ketelaar, P.;
Eggink, G.; Witholt, B. Appl. Environ. Microbiol. 1988, 54,
2924–2932.
References and notes
24. Riesenberg, D.; Menzel, K.; Schulz, V.; Schumann, K.; Veith,
G.; Zuber, G.; Knorre, W. A. Appl. Microbiol. Biotechnol.
1990, 34, 77–82.
1. Slaughter, J. C. Biol. Rev. 1999, 7, 259–276.
2. Pickenhagen, W. In Flavor Chemistry: Thirty Years of
Progress; Teranishi, R., Wick, E. L., Hornstein, I., Eds.;
Kluwer Academic/Plenum: New York, 1999; p 75.
25. Cramer, A.; Raillard, S. A.; Bermudez, E.; Stemmer, W. P.
Nature 1998, 391, 288–291.
3. Furaneolw is a trademark of Firmenich, Geneva.
26. Decnop, C.; van Dort, J. M.; de Hey, J. T. US Patent 5,149,
840, 1992.
4. Tressel, R.; Rewicki, D. In Flavor Chemistry: Thirty Years of